Redundant Innate and Adaptive Sources of IL17 Production Drive Colon Tumorigenesis.
about
Targeting the Tumor Microenvironment: The Protumor Effects of IL-17 Related to Cancer TypeRegulation of TH17 Cells and Associated Cytokines in Wound Healing, Tissue Regeneration, and Carcinogenesis.The myeloid immune signature of enterotoxigenic Bacteroides fragilis-induced murine colon tumorigenesisClinicopathologic parameters associated with postoperative complications and risk factors for tumor recurrence and mortality after tumor resection of patients with colorectal cancer.Interleukin-17A Promotes Lung Tumor Progression through Neutrophil Attraction to Tumor Sites and Mediating Resistance to PD-1 Blockade.Microbiota as a mediator of cancer progression and therapy.Prevention of colitis-associated cancer by selective targeting of immunoproteasome subunit LMP7.Mucosa-associated invariant T cells infiltrate hepatic metastases in patients with colorectal carcinoma but are rendered dysfunctional within and adjacent to tumor microenvironment.Novel Helicobacter species H.japonicum isolated from laboratory mice from Japan induces typhlocolitis and lower bowel carcinoma in C57BL/129 IL10-/- mice.The microbiome and the hallmarks of cancer.HEB is required for the specification of fetal IL-17-producing γδ T cells.Th17, synchronically increased with Treg and Breg, promoted by tumor cells via cell-contact in primary hepatic carcinoma.Bacteroides fragilis Toxin Coordinates a Pro-carcinogenic Inflammatory Cascade via Targeting of Colonic Epithelial Cells.A Two-Component System Regulates Bacteroides fragilis Toxin to Maintain Intestinal Homeostasis and Prevent Lethal Disease.Type 2 Innate Lymphocytes Actuate Immunity Against Tumours and Limit Cancer Metastasis.Evolving notions on immune response in colorectal cancer and their implications for biomarker development.Oral IL-10 suppresses colon carcinogenesis via elimination of pathogenicCD4+ T-cells and induction of antitumor CD8+ T-cell activity.Microbiota effects on cancer: from risks to therapies.
P2860
Q28066522-17491640-4B2B-4602-965A-7B4F0EC60D5DQ33755232-838F6548-77FA-4C65-9FD1-C3A0430BA5C8Q37507187-7DAAD3F0-0EEF-45C1-8E95-D562F0EC3B4AQ38677921-A89DAC78-040F-4355-9A9D-7F52B3A7EB74Q38797202-8F80C54F-3D22-4704-A50C-A5E82DBE0360Q38935534-7BF456F0-2873-48F8-8AF4-12544853F80DQ40062442-FF2E2D77-C22E-49D3-9A20-DB8B9E0B7FA1Q40097622-53380E9F-93C9-43BB-959B-904AFB647292Q40531526-039E1ABC-3F4C-4911-BFB8-BC4857983C8BQ42362158-052A36BA-4CE6-49DE-A74B-E46D4499FB9BQ47102408-49F4BFE9-4545-4A0A-A8BA-6C1FD24DC418Q47218277-6411086C-9D14-49D0-8334-8BDEF0B0E1E9Q49339623-E5FC3885-98CD-48B2-8C6A-F242EF239AD5Q49885269-0016600E-8401-4441-87B0-C00EF4E0F02AQ50025803-DF7EE073-C38F-4850-9B86-4B99D726E2EFQ50098505-56350685-5095-44B0-88FA-C3B37F0683A4Q53177500-619FEF5D-7530-454D-9524-96F2AF868EBFQ54225597-486C2C9B-28F6-4BB8-AE64-D903ED021313
P2860
Redundant Innate and Adaptive Sources of IL17 Production Drive Colon Tumorigenesis.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Redundant Innate and Adaptive Sources of IL17 Production Drive Colon Tumorigenesis.
@en
type
label
Redundant Innate and Adaptive Sources of IL17 Production Drive Colon Tumorigenesis.
@en
prefLabel
Redundant Innate and Adaptive Sources of IL17 Production Drive Colon Tumorigenesis.
@en
P2093
P2860
P1433
P1476
Redundant Innate and Adaptive Sources of IL17 Production Drive Colon Tumorigenesis.
@en
P2093
April C Roslani
Cynthia L Sears
David L Huso
Drew M Pardoll
Elizabeth C Wick
Franck Housseau
Hongni Fan
Jamunarani S Vadivelu
Jane W Wanyiri
P2860
P304
P356
10.1158/0008-5472.CAN-15-0749
P407
P577
2016-02-15T00:00:00Z